Antiretroviral therapy coverage for PMTCT in Ghana

Ghana: Antiretroviral therapy coverage for PMTCT was 99.0% in 2024. ◆ Volatile

Latest (2024)
99.0%
Change on year
up 10.0%
World rank
5th
of 84 countries
All-time high
99.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage for PMTCT in Ghana, 2000–2024

0204060801002000201220242000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 0 % of pregnant women living with HIV2003: 0 % of pregnant women living with HIV2004: 1 % of pregnant women living with HIV2005: 3 % of pregnant women living with HIV2006: 8 % of pregnant women living with HIV2007: 28 % of pregnant women living with HIV2008: 32 % of pregnant women living with HIV2009: 24 % of pregnant women living with HIV2010: 38 % of pregnant women living with HIV2011: 52 % of pregnant women living with HIV2012: 58 % of pregnant women living with HIV2013: 47 % of pregnant women living with HIV2014: 55 % of pregnant women living with HIV2015: 52 % of pregnant women living with HIV2016: 65 % of pregnant women living with HIV2017: 74 % of pregnant women living with HIV2018: 80 % of pregnant women living with HIV2019: 78 % of pregnant women living with HIV2020: 82 % of pregnant women living with HIV2021: 86 % of pregnant women living with HIV2022: 88 % of pregnant women living with HIV2023: 90 % of pregnant women living with HIV2024: 99 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

The most recent figure for antiretroviral therapy coverage for pmtct in Ghana is 99.0%, measured in 2024. That is the highest value across all 25 years on record.

The figure is up 10.0% on the previous year and up 80.0% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Ghana peaked at 99.0% in 2024 and was at its lowest, 0.0%, in 2000.

Ghana ranks 5th of 84 countries on this measure, in the top 10%.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Ghana, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Ghana, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 1.0%
2005 3.0% +200.0%
2006 8.0% +166.7%
2007 28.0% +250.0%
2008 32.0% +14.3%
2009 24.0% -25.0%
2010 38.0% +58.3%
2011 52.0% +36.8%
2012 58.0% +11.5%
2013 47.0% -19.0%
2014 55.0% +17.0%
2015 52.0% -5.5%
2016 65.0% +25.0%
2017 74.0% +13.8%
2018 80.0% +8.1%
2019 78.0% -2.5%
2020 82.0% +5.1%
2021 86.0% +4.9%
2022 88.0% +2.3%
2023 90.0% +2.3%
2024 99.0% +10.0%

Ghana compared with similar countries

  • Ghana's 99.0% is above the median for lower middle income countries, which is 83.5%, 1.2× the median. (32 countries reporting)
  • Ghana's 99.0% is above the median for Sub-Saharan Africa, which is 82.0%, 1.2× the median. (41 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Ghana changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2007 +250.0% 8.0% 28.0%
2005 +200.0% 1.0% 3.0%
2006 +166.7% 3.0% 8.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 9.6% 0.0% 32.0% 10
2010s 59.9% 38.0% 80.0% 10
2020s 89.0% 82.0% 99.0% 5

Countries ranked near Ghana

  1. 5 Malaysia 99.0% compare
  2. 5 Rwanda 99.0% compare
  3. 5 Tanzania 99.0% compare

See the full ranking of 99 places →

More health data for Ghana

All data for Ghana →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Ghana?
Antiretroviral therapy coverage for pmtct in Ghana was 99.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Ghana?
The highest recorded value was 99.0% in 2024.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Ghana?
The lowest recorded value was 0.0% in 2000.
How does Ghana rank for antiretroviral therapy coverage for pmtct?
Ghana ranks 5th out of 84 countries with data for 2024.
Is antiretroviral therapy coverage for pmtct rising or falling in Ghana?
Over the last ten years it is up 80.0%. The long-run trend across the full record is volatile.
Where does this Ghana data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Ghana. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 17 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/ghana/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/ghana/">Antiretroviral therapy coverage for PMTCT in Ghana</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).